Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. The segment has a high entry barrier, driven by high production complexity and the need of specific Know-How. Xbrane currently possess its own expertise within production of complex generics with slow release formulation and unique technologies for producing proteins efficiently.
Providing affordable high demand complex generics for critical diseases to enable global health equality.
Becoming a global leader within our portfolio of high demand complex generics.